Search

Taisei Kinoshita

from San Jose, CA
Age ~57
Get Report
Related to:
Akiyo Kinoshita
Connected to:
Colette A Kinoshita, 69Cullen B Kinoshita, 46Darrel S Kinoshita, 71Gary D Kinoshita, 69Kan Kinoshita, 58Katsumi Kinoshita, 60Megumi Kinoshita, 57Michael S Kinoshita, 72Michiko Kinoshita, 62Richard Y Kinoshita, 52

Taisei Kinoshita Phones & Addresses

  • San Jose, CA
  • 688 Mariners Island Blvd, San Mateo, CA 94404 (650) 356-0411
  • Foster City, CA
  • 1469 Bellevue Ave, Burlingame, CA 94010 (650) 347-3546
  • South San Francisco, CA

Work

Company: Pharmacyclics Feb 2014 to Nov 2019 Position: Director of research

Education

Degree: Doctorates, Doctor of Philosophy School / High School: The University of Tokyo 1992 to 1995 Specialities: Biology

Skills

Drug Development • Biochemistry • Cell Culture • Protein Chemistry • Drug Discovery • Medicinal Chemistry • Cell • Life Sciences • Immunology • Ind • Biotechnology • Cell Biology • Glp • Molecular Biology • Pharmaceutical Industry • In Vitro • Antibodies • Western Blotting • Biopharmaceuticals • Cancer • Pcr • Pharmacology • Elisa

Industries

Biotechnology

Resumes

Resumes

Taisei Kinoshita Photo 1

Head Of Biology

View page
Location:
San Francisco, CA
Industry:
Biotechnology
Work:
Pharmacyclics Feb 2014 - Nov 2019
Director of Research
Rigel Pharmaceuticals Inc. Sep 2001 - Feb 2014
Senior Director
Dnax Research Institute Feb 1, 1993 - Oct 1, 1994
Visiting Student
Biomea Fusion Feb 1, 1993 - Oct 1, 1994
Head of Biology
Education:
The University of Tokyo 1992 - 1995
Doctorates, Doctor of Philosophy, Biology
Skills:
Drug Development
Biochemistry
Cell Culture
Protein Chemistry
Drug Discovery
Medicinal Chemistry
Cell
Life Sciences
Immunology
Ind
Biotechnology
Cell Biology
Glp
Molecular Biology
Pharmaceutical Industry
In Vitro
Antibodies
Western Blotting
Biopharmaceuticals
Cancer
Pcr
Pharmacology
Elisa

Publications

Us Patents

Methods Of Identifying Compounds That Modulate Il-4 Receptor-Mediated Ige Synthesis Utilizing An Adenosine Kinase

View page
US Patent:
7141434, Nov 28, 2006
Filed:
Jul 16, 2002
Appl. No.:
10/197381
Inventors:
Esteban Masuda - Menlo Park CA, US
Todd M. Kinsella - Fayetteville NC, US
Justin E. Warner - San Francisco CA, US
Taisei Kinoshita - San Mateo CA, US
Mark K. Bennett - Moraga CA, US
David C. Anderson - San Bruno CA, US
Assignee:
Rigel Pharmaceuticals, Inc. - South San Francisco CA
International Classification:
G01N 33/566
G01N 33/567
A61K 45/00
A61K 38/00
US Classification:
436501, 436503, 424 852, 514 12
Abstract:
The present provides compounds capable of modulating IL-4 receptor-mediated IgE production, as well as IL-4 induced processes associated therewith, methods and kits for identifying such compounds that utilize an adenosine kinase as a surrogate analyte and methods of using the compounds in a variety of in vitro, in vitro and ex vivo contexts.

Methods Of Identifying Compounds That Modulate Il-4 Receptor-Mediated Ige Synthesis Utilizing A B-Cell Associated Protein

View page
US Patent:
7189523, Mar 13, 2007
Filed:
Jul 16, 2002
Appl. No.:
10/197919
Inventors:
Esteban Masuda - Menlo Park CA, US
Todd M. Kinsella - Fayetteville NC, US
Justin E. Warner - San Francisco CA, US
Taisei Kinoshita - San Mateo CA, US
Mark K. Bennett - Moraga CA, US
David C. Anderson - San Bruno CA, US
Assignee:
Rigel Pharmaceuticals, Inc. - South San Francisco CA
International Classification:
G01N 33/566
G01N 33/567
C07K 4/00
A61K 45/00
A61K 38/00
US Classification:
435 721, 436501, 436503, 424 852, 514 12, 435 724, 530351
Abstract:
The present provides compounds capable of modulating IL-4 receptor-mediated IgE production, as well as IL-4 induced processes associated therewith, methods and kits for identifying such compounds that utilize a BAP-37 as a surrogate analyte and methods of using the compounds in a variety of in vitro, in vitro and ex vivo contexts.

Methods Of Identifying Compounds That Modulate Il-4 Receptor Mediated Ige Synthesis Utilizing A Clld8 Protein

View page
US Patent:
7208289, Apr 24, 2007
Filed:
Dec 30, 2004
Appl. No.:
11/027949
Inventors:
Esteban Masuda - Menlo Park CA, US
Todd M. Kinsella - Fayetteville NC, US
Justin E. Warner - San Francisco CA, US
Taisei Kinoshita - San Mateo CA, US
Mark K. Bennett - Moraga CA, US
David C. Anderson - San Bruno CA, US
Assignee:
Rigel Pharmaceuticals, Inc. - South San Francisco CA
International Classification:
C12Q 1/37
US Classification:
435 23, 435 24, 435375, 530300
Abstract:
The present provides compounds capable of modulating IL-4 receptor-mediated IgE production, as well as IL-4 induced processes associated therewith, methods and kits for identifying such compounds that utilize a CLLD8 protein as a surrogate analyte and methods of using the compounds in a variety of in vitro, in vitro and ex vivo contexts.

Methods Of Identifying Compounds That Modulate Il-4 Receptor-Mediated Ige Synthesis Utilizing A C-Myc Protein

View page
US Patent:
7241581, Jul 10, 2007
Filed:
Aug 16, 2002
Appl. No.:
10/222729
Inventors:
Esteban Masuda - Menlo Park CA, US
Todd M. Kinsella - Fayetteville NC, US
Justin E. Warner - San Francisco CA, US
Taisei Kinoshita - San Mateo CA, US
Mark K. Bennett - Moraga CA, US
David C. Anderson - San Bruno CA, US
Assignee:
Rigel Pharmaceuticals, Inc. - South San Francisco CA
International Classification:
G01N 33/566
G01N 33/53
G01N 33/542
A61K 38/20
A61K 45/00
US Classification:
435 721, 435 793, 435471, 424 852, 514 12
Abstract:
The present provides compounds capable of modulating IL-4 receptor-mediated IgE production, as well as IL-4 induced processes associated therewith, methods and kits for identifying such compounds that utilize a c-Myc protein as a surrogate analyte and methods of using the compounds in a variety of in vitro, in vitro and ex vivo contexts.

Methods Of Identifying Compounds That Modulate Il-4 Receptor-Mediated Ige Synthesis Utilizing A Chloride Intracellular Channel 1 Protein

View page
US Patent:
7374894, May 20, 2008
Filed:
Jul 16, 2002
Appl. No.:
10/197945
Inventors:
Esteban Masuda - Menlo Park CA, US
Todd M. Kinsella - Fayetteville NC, US
Justin E. Warner - San Francisco CA, US
Taisei Kinoshita - San Mateo CA, US
Mark K. Bennett - Moraga CA, US
David C. Anderson - San Bruno CA, US
Assignee:
Rigel Pharmaceuticals, Inc. - South San Francisco CA
International Classification:
G01N 33/53
G01N 33/00
G01N 33/566
A61K 45/00
A61K 38/00
C07K 17/00
US Classification:
435 721, 424 852, 435 724, 436501, 436503, 514 12, 530351
Abstract:
The present provides compounds capable of modulating IL-4 receptor-mediated IgE production, as well as IL 4 induced processes associated therewith, methods and kits for identifying such compounds that utilize a chloride intracellular channel 1 (CLIC1) as a surrogate analyte and methods of using the compounds in a variety of in vitro, in vivo and ex vivo contexts.

Methods Of Identifying Compounds That Modulate Il-4 Receptor-Mediated Ige Synthesis Utilizing A Thioredoxin-Like 32 Kda Protein

View page
US Patent:
7378251, May 27, 2008
Filed:
Jul 16, 2002
Appl. No.:
10/197962
Inventors:
Esteban Masuda - Menlo Park CA, US
Todd M. Kinsella - Fayetteville NC, US
Justin E. Warner - San Fancisco CA, US
Taisei Kinoshita - San Mateo CA, US
Mark K. Bennett - Moraga CA, US
David C. Anderson - San Bruno CA, US
Assignee:
Rigel Pharmaceuticals, Inc. - South San Francisco CA
International Classification:
G01N 33/53
US Classification:
435 72
Abstract:
The present provides compounds capable of modulating IL-4 receptor-mediated IgE production, as well as IL-4 induced processes associated therewith, methods and kits for identifying such compounds that utilize a thioredoxin-like 32 kDa protein (TXNL) as a surrogate analyte and methods of using the compounds in a variety of in vitro, in vitro and ex vivo contexts.

Methods Of Identifying Compounds That Modulate Il-4 Receptor Mediated Ige Synthesis Utilizing A Clld8 Protein

View page
US Patent:
7422867, Sep 9, 2008
Filed:
Apr 4, 2007
Appl. No.:
11/784176
Inventors:
Esteban Masuda - Menlo Park CA, US
Todd M. Kinsella - Redwood City CA, US
Justin E. Warner - San Francisco CA, US
Taisei Kinoshita - San Mateo CA, US
Mark K. Bennett - Moraga CA, US
David C. Anderson - San Bruno CA, US
Assignee:
Rigel Pharmaceuticals, Inc. - South San Francisco CA
International Classification:
C12Q 1/37
US Classification:
435 23, 435 16, 435 24, 435375, 530300
Abstract:
The present provides compounds capable of modulating IL-4 receptor-mediated IgE production, as well as IL-4 induced processes associated therewith, methods and kits for identifying such compounds that utilize a CLLD8 protein as a surrogate analyte and methods of using the compounds in a variety of in vitro, in vitro and ex vivo contexts.

4-Pyrimidineamine Compounds And Their Uses As Anti-Proliferative Agents

View page
US Patent:
7482351, Jan 27, 2009
Filed:
Jun 29, 2005
Appl. No.:
11/171970
Inventors:
Rajinder Singh - Belmont CA, US
Ankush Argade - Foster City CA, US
David Carroll - San Francisco CA, US
Tarikere Gururaja - Santa Clara CA, US
Taisei Kinoshita - San Mateo CA, US
Assignee:
Rigel Pharmaceuticals, Inc. - South San Francisco CA
International Classification:
A01N 43/54
C07D 239/42
C07D 401/04
C07D 239/02
US Classification:
514256, 544326
Abstract:
The present disclosure provides 4-pyrimidineamine compounds having antiproliferative activity, compositions comprising the compounds and methods of using the compounds to inhibit cellular proliferation and to treat proliferative diseases such as tumorigenic cancers.
Control profile
Taisei Kinoshita from San Jose, CA, age ~57 Get Report